Stocktoria
Twist Bioscience Corp TWST
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2018-10-31
Twist Bioscience Corp financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $376.6M | $313.0M | $245.1M | $203.6M | $132.3M |
| R&D expense | $80.3M | $90.9M | $106.9M | $120.3M | $69.1M |
| SG&A expense | $247.0M | $218.4M | $189.7M | $212.9M | $135.9M |
| Operating income | -$136.3M | -$220.8M | -$217.2M | -$234.8M | -$152.7M |
| Interest expense | — | — | $5,000 | $80,000 | $367,000 |
| Income tax | $719,000 | $560,000 | $1.2M | -$10.4M | -$1.9M |
| Net income | -$77.7M | -$208.7M | -$204.6M | -$217.9M | -$152.1M |
| EPS (diluted) | $-1.30 | $-3.60 | $-3.60 | $-4.04 | $-3.15 |
| Operating cash flow | -$47.6M | -$64.1M | -$142.5M | -$124.4M | -$112.2M |
| Free cash flow | -$75.6M | -$69.2M | -$170.3M | -$226.2M | -$139.3M |
| Cash & equivalents | $183.0M | $226.3M | $286.5M | $378.7M | $465.8M |
| Inventory | $28.3M | $24.1M | $32.1M | $39.3M | $31.8M |
| Total assets | $641.9M | $614.3M | $776.4M | $961.4M | $702.1M |
| Total liabilities | $168.9M | $141.6M | $153.0M | $172.0M | $121.3M |
| Shareholders' equity | $473.0M | $472.7M | $623.4M | $789.4M | $580.8M |
Source: SEC EDGAR filings · CIK 0001581280 · as of 2025-09-30. Facts from filings plus Stocktoria's own computed scores — not investment advice.